Vivanza Biosciences (BOM:530057) Other Financing: ₹0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530057 Vivanza Biosciences Ltd BOM:530057
58 GF Score
Price ₹1.84
GF Value ₹26.58
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Vivanza Biosciences Other Financing?

Vivanza Biosciences BOM:530057 -3.16% 58 Other Financing is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:530057 with a GF Score™ of 58/100 and a GF Value™ of ₹26.58 (Possible Value Trap). The stock has 3 warning signs investors should review.

Vivanza Biosciences's Other Financing for the three months ended in Mar. 2026 was ₹0 Mil.

Vivanza Biosciences's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Vivanza Biosciences Other Financing Historical Data

* Premium members only.

The historical data trend for Vivanza Biosciences's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivanza Biosciences Other Financing Chart

Vivanza Biosciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.99 -4.19 -4.13 -3.51 -2.79

Vivanza Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:530057
58GF Score
Vivanza Biosciences Ltd BOM:530057
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivanza Biosciences Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ₹0 Mil mean?
Vivanza Biosciences (BOM:530057) has a Other Financing of ₹0 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Vivanza Biosciences and its competitors.
Is Vivanza Biosciences' Other Financing too high?
Vivanza Biosciences' current Other Financing is ₹0 Mil. Overall, Vivanza Biosciences has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vivanza Biosciences' Other Financing compare to ZTS?
Vivanza Biosciences' Other Financing of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Vivanza Biosciences and its competitors. Vivanza Biosciences's current Other Financing is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivanza Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Vivanza Biosciences (BOM:530057) is currently considered Possible Value Trap. The stock's GF Value™ is ₹26.58, compared to a current price of ₹1.84 — trading 93.1% below its estimated fair value. The current Other Financing is ₹0 Mil. Vivanza Biosciences' overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Vivanza Biosciences (BOM:530057), the current Other Financing is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivanza Biosciences (BOM:530057) Overvalued in 2026?

Based on GuruFocus' analysis, Vivanza Biosciences stock appears to be undervalued. The current stock price of ₹1.84 is trading 93.1% below its estimated GF Value™ of ₹26.58. GuruFocus considers Vivanza Biosciences to be Possible Value Trap.

Key valuation signals for BOM:530057:

  • Other Financing: ₹0 Mil
  • GF Value™: ₹26.58 vs. price of ₹1.84 (93.1% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the BOM:530057 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vivanza Biosciences Business Description

Address S.G. Highway, 403/TF, Sarthik II, Opposite Rajpath Club, Bodakdev, Ahmedabad, GJ, IND, 380054
Vivanza Biosciences Ltd is a pharmaceutical company. Its core focus areas include research and development, manufacturing, and the distribution of a wide range of pharma and pharmaceutical products. The company's product portfolio includes Medical examination gloves, Injections, Veterinary feeds, and others.
58GF Score

Get the complete analysis for BOM:530057

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1.84
Price
₹26.58
GF Value